Protein kinases controlling PCNA and p53 expression in human ovarian cells

被引:0
作者
Alexander V. Sirotkin
Dmitriy Ovcharenko
Andrej Benčo
Miloš Mlynček
机构
[1] Slovak Centre of Agricultural Studies,Research Institute of Animal Production
[2] University of Texas at Austin,Division of Pharmacology and Toxicology, College of Pharmacy
[3] Konstantin the Philosopher University,undefined
[4] Polyclinics and Hospital of Nitra,undefined
来源
Functional & Integrative Genomics | 2009年 / 9卷
关键词
siRNA; Protein kinase; Ovary; Granulosa; Proliferation; Apoptosis; PCNA; p53;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to identify protein kinases (PKs) involved in the expression of proliferating cell nuclear antigen (PCNA) and p53, markers of proliferation and apoptosis in human ovarian cells. Cultured ovarian granulosa cells were subjected to transfection with 264 small-interfering RNA (siRNA) constructs from a siRNA library, which selectively blocked the expression of 88 known PKs. The efficiency of transfection and siRNA knockdown were validated by fluorescent microscopy, real-time reverse transcription polymerase chain reaction, and immunocytochemical analysis. The expression of PCNA and p53, before and after transfection with siRNA constructs, was evaluated by immunocytochemistry. The siRNA constructs suppressed the expression of their targets molecules by up to 84%. Knockdown of 32 of the 88 PKs inhibited the expression of PCNA, while the knockdown of seven of the PKs stimulated PCNA expression. Knockdown of 30 of the 88 PKs reduced the expression of p53, while knockdown of five PKs enhanced p53 expression. Our results illustrate that siRNA constructs are useful tools for understanding the role of PKs in the control of ovarian cell functions, such as proliferation and apoptosis. The specific knockdown of individual PKs has enabled the identification of a number of new PKs that control the expression of PCNA and p53 in human ovarian cells.
引用
收藏
页码:185 / 195
页数:10
相关论文
共 249 条
  • [1] Amsterdam A(2003)Alternative pathways of ovarian apoptosis: death for life Biochem Pharmacol 66 1355-1362
  • [2] Sasson R(2003)Steroidogenesis and apoptosis in the mammalian ovary Steroids 68 861-867
  • [3] Keren-Tal I(2005)Ovarian function in ruminants Domest Anim Endocrinol 29 305-317
  • [4] Aharoni D(2006)Some p53-binding proteins that can function as arbiters of life and death Cell Death Differ 13 984-993
  • [5] Dantes A(2007)Transcriptional targets of p53 that regulate cellular proliferation Crit Rev Eukaryot Gene Expr 17 73-85
  • [6] Rimon E(2003)Dynamics of Myc/Max/Mad expression during luteinization of primate granulosa cells in vitro: association with periovulatory proliferation Endocrinology 144 1249-1256
  • [7] Land A(2004)Regulation of steroidogenesis by p53 in macaque granulosa cells and H295R human adrenocortical cells Endocrinology 145 5734-5744
  • [8] Cohen T(2006)Current concepts in apoptosis: The physiological suicide program revisited Cell Mol Biol Lett 11 506-525
  • [9] Dor Y(2006)Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy Int J Gynecol Cancer Suppl 1 152-165
  • [10] Hirsh L(2000)The primordial to primary follicle transition Mol Cell Endocrinol 163 53-60